GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
NCT: NCT06578741 · ACTIVE_NOT_RECRUITING
Brief Summary
This study aims to confirm that the benefit-risk assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) remains positive in real-world use and to ensure the adequacy of the TAMBE Device training program.
Frequently Asked Questions
What is GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study?
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study is a clinical trial registered under NCT06578741. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06578741?
The current status of NCT06578741 (GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study) is: ACTIVE_NOT_RECRUITING.
When did GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study start?
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study started on 2024-11-25.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.